MUC5B and idiopathic pulmonary fibrosis: The clinical aspects have been best described in variants in the telomerase and promoter regions of MUC5B. A common variant in MUC5B has the largest effect on IPF risk, but rare variants, such as TERT, are considered more important in disease pathogenicity [5, 7, 8].